Single doses of ergotamine tartrate (0.5 mg.), injected subcutaneously, produce definite vasoconstriction as indicated by a decrease in peripheral blood-flow. Less commonly, vasodilatation is produced, with increased blood-flow. No significant difference in blood-flow change after ergotamine was noted between normals and subjects with liver disease.
No takes yet. Share an insight, caveat, or question.
Abramson et al. (1937) studied this question.